Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: The ANSWER cohort study

Yuki Etani, Yasutaka Okita, Yuichi Maeda, Kohei Tsujimoto, Takaaki Noguchi, Ryu Watanabe, Motomu Hashimoto, Iku Shirasugi, Naoki Nakano, Yuji Nozaki, Chisato Ashida, Yonsu Son, Hidehiko Makino, Yumiko Wada, Ayaka Yoshikawa, Takayuki Fujii, Wataru Yamamoto, Atsushi Kumanogoh, Seiji Okada, Ken Nakata, Kosuke Ebina

Open source

DOI: 10.1016/j.jbspin.2026.106080
Published: 2026-10
Container: Joint Bone Spine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jbspin.2026.106080,
  title = {Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: The ANSWER cohort study},
  author = {Yuki Etani and Yasutaka Okita and Yuichi Maeda and Kohei Tsujimoto and Takaaki Noguchi and Ryu Watanabe and Motomu Hashimoto and Iku Shirasugi and Naoki Nakano and Yuji Nozaki and Chisato Ashida and Yonsu Son and Hidehiko Makino and Yumiko Wada and Ayaka Yoshikawa and Takayuki Fujii and Wataru Yamamoto and Atsushi Kumanogoh and Seiji Okada and Ken Nakata and Kosuke Ebina},
  year = {2026},
  journal = {Joint Bone Spine},
  doi = {10.1016/j.jbspin.2026.106080},
  url = {https://doi.org/10.1016/j.jbspin.2026.106080}
}

RIS

TY  - JOUR
TI  - Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: The ANSWER cohort study
AU  - Yuki Etani
AU  - Yasutaka Okita
AU  - Yuichi Maeda
AU  - Kohei Tsujimoto
AU  - Takaaki Noguchi
AU  - Ryu Watanabe
AU  - Motomu Hashimoto
AU  - Iku Shirasugi
AU  - Naoki Nakano
AU  - Yuji Nozaki
AU  - Chisato Ashida
AU  - Yonsu Son
AU  - Hidehiko Makino
AU  - Yumiko Wada
AU  - Ayaka Yoshikawa
AU  - Takayuki Fujii
AU  - Wataru Yamamoto
AU  - Atsushi Kumanogoh
AU  - Seiji Okada
AU  - Ken Nakata
AU  - Kosuke Ebina
PY  - 2026
JO  - Joint Bone Spine
DO  - 10.1016/j.jbspin.2026.106080
UR  - https://doi.org/10.1016/j.jbspin.2026.106080
ER  -

APA

Etani, Y., Okita, Y., Maeda, Y., Tsujimoto, K., Noguchi, T., Watanabe, R., Hashimoto, M., Shirasugi, I., Nakano, N., Nozaki, Y., Ashida, C., Son, Y., Makino, H., Wada, Y., Yoshikawa, A., Fujii, T., Yamamoto, W., Kumanogoh, A., Okada, S., Nakata, K., & Ebina, K. (2026). Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: The ANSWER cohort study. Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2026.106080

Source records

crossref · retrieved 2026-09-26T22:47:51.835Z